Latest News for SMSMY
NEEDHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced the appointment of Mark Sims as the Company's Chief Commercial Officer, effective July 6, 2026. Mr. Sims will lead Candel's commercial…
Sims Metal Management (SMSMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how GDS Holdings (GDS) and Sims Metal Management Ltd. (SMSMY) have performed compared to their sector so far this year.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SMSMY.
Senate Trading
No Senate trades found for SMSMY.
U.S. House Trading
No House trades found for SMSMY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.